Inhibition profiles of Voriconazole against acetylcholinesterase, α-glycosidase, and human carbonic anhydrase I and II isoenzymes
Özet
In this work, the inhibitory activity of Voriconazole was measured against some metabolic enzymes, including human carbonic anhydrase (hCA) I and II isoenzymes, acetylcholinesterase (AChE), and α-glycosidase; the results were compared with standard compounds including acetazolamide, tacrine, and acarbose. Half maximal inhibition concentration (IC50) values were obtained from the enzyme activity (%)-[Voriconazole] graphs, whereas Ki values were calculated from the Lineweaver-Burk graphs. According to the results, the IC50 value of Voriconazole was 40.77 nM for α-glycosidase, while the mean inhibition constant (Ki) value was 17.47 ± 1.51 nM for α-glycosidase. The results make an important contribution to drug design and have pharmacological applications. In addition, the Voriconazole compound demonstrated excellent inhibitory effects against AChE and hCA isoforms I and II. Voriconazole had Ki values of 29.13 ± 3.57 nM against hCA I, 15.92 ± 1.90 nM against hCA II, and 10.50 ± 2.46 nM against AChE.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Topal, Fevzi | |
| dc.date.accessioned | 2026-10-22T10:20:23.131723422Z | |
| dc.date.available | 2026-10-22T10:20:23.131723422Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | In this work, the inhibitory activity of Voriconazole was measured against some metabolic enzymes, including human carbonic anhydrase (hCA) I and II isoenzymes, acetylcholinesterase (AChE), and α-glycosidase; the results were compared with standard compounds including acetazolamide, tacrine, and acarbose. Half maximal inhibition concentration (IC50) values were obtained from the enzyme activity (%)-[Voriconazole] graphs, whereas Ki values were calculated from the Lineweaver-Burk graphs. According to the results, the IC50 value of Voriconazole was 40.77 nM for α-glycosidase, while the mean inhibition constant (Ki) value was 17.47 ± 1.51 nM for α-glycosidase. The results make an important contribution to drug design and have pharmacological applications. In addition, the Voriconazole compound demonstrated excellent inhibitory effects against AChE and hCA isoforms I and II. Voriconazole had Ki values of 29.13 ± 3.57 nM against hCA I, 15.92 ± 1.90 nM against hCA II, and 10.50 ± 2.46 nM against AChE. | |
| dc.identifier.articlenumber | e22385 | |
| dc.identifier.doi | 10.1002/jbt.22385 | |
| dc.identifier.eissn | 1099-0461 | |
| dc.identifier.issn | 1095-6670 | |
| dc.identifier.issue | 10 | |
| dc.identifier.pmid | 31478295 | |
| dc.identifier.scopus | 2-s2.0-85071606975 | |
| dc.identifier.startpage | e22385 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/12661 | |
| dc.identifier.volume | 33 | |
| dc.identifier.wos | WOS:000484846800001 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc. | |
| dc.relation.ispartof | Journal of Biochemical and Molecular Toxicology | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | acetylcholinesterase | |
| dc.subject | carbonic anhydrase | |
| dc.subject | enzyme inhibition | |
| dc.subject | voriconazole | |
| dc.subject | α-glycosidase | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Toxicology | |
| dc.subject.other | Acetylcholinesterase | |
| dc.subject.other | Antifungal Agents | |
| dc.subject.other | Carbonic Anhydrase I | |
| dc.subject.other | Carbonic Anhydrase II | |
| dc.subject.other | Carbonic Anhydrase Inhibitors | |
| dc.subject.other | Glycoside Hydrolases | |
| dc.subject.other | Humans | |
| dc.subject.other | Voriconazole | |
| dc.subject.other | acarbose | |
| dc.subject.other | acetazolamide | |
| dc.subject.other | alpha glycosidase | |
| dc.subject.other | carbonate dehydratase I | |
| dc.subject.other | carbonate dehydratase II | |
| dc.subject.other | glycosidase | |
| dc.subject.other | tacrine | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | antifungal agent | |
| dc.subject.other | carbonate dehydratase inhibitor | |
| dc.subject.other | Article | |
| dc.subject.other | competitive inhibition | |
| dc.subject.other | controlled study | |
| dc.subject.other | drug design | |
| dc.subject.other | enzyme activity | |
| dc.subject.other | enzyme inhibition | |
| dc.subject.other | enzyme inhibition assay | |
| dc.subject.other | human | |
| dc.subject.other | IC50 | |
| dc.subject.other | inhibition constant | |
| dc.subject.other | drug effect | |
| dc.title | Inhibition profiles of Voriconazole against acetylcholinesterase, α-glycosidase, and human carbonic anhydrase I and II isoenzymes | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.openalex | 30 | |
| rdl.citation.scopus | 32 | |
| rdl.citation.wos | 30 | |
| rdl.department | Department of Chemical and Chemical Processing Technologies, Laboratory Technology Program, Gumushane Vocational School, Gumushane University, Gumushane, Turkey | |
| rdl.oa.status | closed | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

